Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

Vineti Grabs $33M Series C Extension

2020-10-17
SAN FRANCISCO, CA, Vineti announced the closing of a $33 million extension to its Series C financing, led by Cardinal Health.
Vineti, a leading digital platform of record for personalized therapeutics, today announced the closing of a $33 million extension to its Series C financing. The new financing will support further expansion of the company's Personalized Therapy Management (PTM) platform for personalized and high-value advanced therapies.

The Series C extension is led by Cardinal Health, with participation from Marc Benioff and existing Vineti investors, including Canaan Partners, Threshold Ventures (formerly DFJ), Section 32, Casdin Capital, Novartis Pharma AG, McKesson Ventures, and LifeForce Capital, along with other undisclosed entities. Eli Casdin, Chief Investment Officer and Founder of Casdin Capital, will join Vineti's Board of Directors.

Vineti is the first commercial cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of 21st century medicine. The Vineti platform integrates logistics, manufacturing and clinical data to improve product performance overall. Caregivers and pharmaceutical pioneers are empowered to help more patients more effectively and safely, treatments are better understood and improved over time, and most importantly, there's an opportunity to provide greater health outcomes-and cures-to patients in need.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors